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We describe four children with a novel primary immunodeﬁciency consisting of speciﬁc natural-killer (NK) cell
deﬁciency and susceptibility to viral diseases. One child developed an Epstein-Barr virus–driven lymphoproliferative
disorder; two others developed severe respiratory illnesses of probable viral etiology. The four patients are related
and belong to a large inbred kindred of Irish nomadic descent, which suggests autosomal recessive inheritance of
this defect. A genomewide scan identiﬁed a single 12-Mb region on chromosome 8p11.23-q11.21 that was linked
to this immunodeﬁciency (maximum LOD score 4.51). The mapping of the disease-causing genomic region paves
the way for the identiﬁcation of a novel pathway governing NK cell differentiation in humans.
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Natural killer (NK) cells are circulating cytotoxic lym-
phocytes lacking antigen-speciﬁc T-cell and B-cell recep-
tors (Yokoyama and Plougastel 2003;Moretta andMor-
etta 2004; Vivier et al. 2004; Lanier 2005). They have
been shown to exert potent and nonredundant antiviral
activity in the mouse (Brown et al. 2001; Casanova et
al. 2001; Lee et al. 2001; Smith et al. 2002; French and
Yokoyama 2003; Yokoyama and Plougastel 2003; Des-
rosiers et al. 2005; Lodoen and Lanier 2005), but their
function in human host defenses remains unclear, partly
because of the lack of well-deﬁned inherited disorders
associated with a speciﬁc deﬁciency in NK cell devel-
opment (Orange 2002). A previously healthy girl who
presented with disseminated varicella-zoster virus (VZV)
infection at age 13 years, which was followed by cy-
tomegalovirus (CMV) pneumonitis and cutaneous her-
pes simplex virus (HSV) infections, was described as
lacking NK cells (Biron et al. 1989). However, this pa-
tient has since died of aplastic anemia, which suggests
that she may have had an acquired, global hematopoietic
condition (Orange 2002). A second patient was recently
described who had NK cell deﬁciency and recurrent var-
icella infections, which led to death at age 2 years (Et-
zioni et al. 2005). The parents were consanguineous, and
viral infections had begun early in life, which suggests
that this child had an inherited defect. However, NK cell
counts were not determined before the ﬁrst viral infec-
tion in these two unrelated patients, and VZV has been
shown to decrease NK cell counts in otherwise healthy
children (Vossen et al. 2005).
We recently described the ﬁrst reported form of fa-
milial NK cell deﬁciency in two affected sisters without
T-cell lymphopenia (Bernard et al. 2004). The older child
died from CMV infection, whereas the second child re-
mained healthy at age 7 years and had a persistent lack
of NK cells with no diagnosed viral infection (C.E., E.J.,
and J.-L.C., unpublished data). This strongly suggests
that the NK cell deﬁciency was an inherited defect in
this family. Furthermore, like the two previously men-
tioned reports, these ﬁndings are consistent with the hy-
pothesis that this immunodeﬁciency leads to suscepti-
bility to herpes viruses, such as CMV, VZV, HSV, and
Epstein-Barr virus (EBV). The molecular basis of the NK
cell deﬁciency was found to be excessive lymphoid ap-
optosis with impaired survival responses to interleukin
2 (IL-2) and IL-15 (C.E., E.J., and J.-L.C., unpublished
data). However, these two siblings have a more gener-
alized condition, because they also displayed severe in-
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Figure 1 Pedigree of the family. Individuals represented by a symbol with an asterisk (*) were available for genotyping (primary genome
scan), whereas individuals represented by a symbol with a small circle were genotyped for only 8p12-q12.2 (ﬁne mapping). The absolute NK
cell count (measured in cells/mm3 of whole blood) and the percentage of lymphocytes that were NK cells in the ﬁrst whole-blood sample analyzed
are indicated for each individual tested.
trauterine growth retardation, mild facial dysmorphy,
and neutropenia. There is therefore no known Mende-
lian disorder associated exclusively with selectiveNKcell
deﬁciency (McKusick 1998). We describe here a large
consanguineous kindred with NK cell deﬁciency in four
members, including one patient with EBV-driven lym-
phoproliferative disorder and two patients with severe
pneumonitis of probable viral origin. We also show that
this novel NK cell–speciﬁc primary immunodeﬁciency is
autosomal recessive and maps to the centromeric region
of chromosome 8.
The index case patient (P3) was born in 1996 (ﬁg. 1).
At age 18 mo, he presented with failure to thrive, he-
patomegaly, splenomegaly, and peripheral lymphadeno-
pathy. His condition may have reﬂected primary EBV
infection but remained unexplained. It eventually re-
solved without treatment. The patient had previously
had relatively benign viral infections of childhood, with
recurrent respiratory tract infections, herpetic stomatitis,
and molluscum contagiosum. At age 2 years and 9 mo,
he developed an EBV-related lymphoproliferative dis-
order in the small bowel, and the resulting tumor was
surgically removed. Neither chemotherapy nor immu-
notherapy was given. Immunohistochemical staining of
the lesion showed morphologic appearances of malig-
nant lymphoma with inﬁltrative and destructive growth
and atypical cytology, but classiﬁcation was difﬁcult. Re-
sults of immunohistochemical staining for the B-cell
marker CD20 and the EBV latent membrane protein
antigen were positive in many large cells. A draining
lymph node biopsy specimen showed inﬁltration with
reactive histiocytes, and a blood smear provided evi-
dence of hemophagocytosis by monocytes. The patient
has remained well since his recovery. He is currently 9
years old and is not receiving treatment.
Two of the three other affected family members ex-
perienced frequent lung infections: P2 (born in 1991)
and P4 (born in 1997). P2 was found to have foci of
bronchiectasis, a probable consequence of severe viral
illnesses. In 2004, P4 had a serious infection, and a lung
biopsy specimen showed changes suggestive of viral in-
fection; however, CMV was not detected, and adeno-
virus was suspected but not proven. P1, born in 1999,
was less severely ill than the others and has had no
documented viral infectious diseases. At the last follow-
up in 2005, the four patients had improved clinically,
although both P2 and P4 continued to experience re-
peated respiratory infections without a speciﬁc etiologic
agent identiﬁed. There was no documented intrauterine
growth retardation; however, all four patients were !3rd
percentile for height and weight at their ﬁrst presenta-
tion, a probable consequence of recurrent infections, and
this below-average growth has continued. Serological
tests for EBV (testing for immunoglobulin M [IgM] to
viral capsid antigen and IgG to EBV nuclear antigen)
were paradoxically negative for P3 at 4 and 9 years old,
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whereas the other three patients tested positive for IgG
to EBV nuclear antigen. Serological tests for HSV were
positive for all four patients, serological tests for VZV
were positive for P1 and P4 but negative for P2 and P3,
and serological tests for CMV were negative for all four
patients. P3 also mounted an antibody response to HSV
and to mumps, measles, and rubella viruses (possibly
because of vaccination). This patient had no antibodies
against CMV and VZV.
Immunological investigations were performed for the
proband shortly after removal of the lymphoprolifera-
tive lesion, and a speciﬁc lack of NK cells in the blood
was found (table 1). When initially phenotyped in 1998,
P3 showed an NK cell count of 9 cells (CD3, CD16,
and CD56) per mm3 of whole blood (!1% of lympho-
cytes) by ﬂow cytometry (methods available on request).
We checked whether the NK cell deﬁciency was persis-
tent by testing whole-blood samples from P3 on four
other occasions (twice in 1998, once in 2002, and once
in 2003). NK cell counts were very low on all occasions:
40, 43, 37, and 6 cells/mm3 (equivalent to 0%–2% of
lymphocytes). We looked for a similar phenotype in
other family members. Three additional family members
(P1, P2, and P4) had very low NK cell counts. Whole-
blood samples from P2 were tested seven times, and the
absolute NK cell counts were 77 and 32 cells/mm3 in
2000 and 174, 43, 30, 90, and 24 cells/mm3 in 2003
(1%–3%). The NK cell counts of samples from P4 were
149 cells/mm3 in 2000, 30 and 29 cells/mm3 in 2001,
and 50 and 116 cells/mm3 in 2002 (1%–3%). Whole-
blood samples from P1 were tested eight times. At age
1 year, P1 had an NK cell count of 83 cells/mm3. In
2001, two samples from P1 were analyzed, with NK cell
counts of 174 and 181 cells/mm3. His NK cell counts
were 81 and 90 cells/mm3 in 2002, 128 and 128 cells/
mm3 in 2003, and 137 cells/mm3 at the last phenotyping
in 2005 (1%–4%). On some occasions, the absolute
number of NK cells was in the normal range in P1,
because of the production of large numbers of lympho-
cytes, but the percentage of NK cells remained low
(!4%). Thus, 4 individuals from this kindred (P1, P2,
P3, and P4) were found to have much lower counts
(generally !100 cells/mm3) and percentages (always
!4%) of NK cells in blood than those of the 14 healthy
family members tested (including 9 children) and of age-
matched unrelated healthy children (table 1) (Comans-
Bitter et al. 1997). One adult (III.6) with an NK cell
count of 161 cells/mm3 was not considered to be NK
cell deﬁcient because the NK cell percentage reached 8%.
Consistent with the small number of NK cells present,
NK cell activity was also impaired. No NK cytotoxic
activity was detected for P3 after the incubation of pe-
ripheral blood mononuclear cells (PBMCs) with the
erythroleukemia K562 cell line or of IL-2–activated
PBMCs with Daudi cells. T cells expressing the NK cell
marker CD56 were also fewer in number in the two
patients tested (P3 and P2) than in age-matched healthy
controls. NK T cells (CD3 and TCRVa24/Vb11)
were rare in P1 (0.02% of lymphocytes) and were pre-
sent at normal levels (0.16%, 0.92%, and 0.22%) in
three siblings with normal NK cell counts. The immu-
nological workup for the four NK-deﬁcient patients was
otherwise unremarkable, with normal numbers of total
lymphocytes, B cells (CD19), T cells (CD3), and CD4
and CD8 T cells, with the possible exception of P3,
who presented with subnormal numbers of CD8T cells.
Finally, T cells from P3 proliferated normally on stim-
ulation by mitogens (concanavalin A and phytohemag-
glutinin), and B cells were able to mount antigen-speciﬁc
antibody responses. Owing to the difﬁculties of not hav-
ing regular access to blood samples from the patients,
the expression of NK receptors unfortunately could not
be studied. Classic and alternative complement levels
and phagocytic respiratory-burst test results were nor-
mal. These 4 individuals thus presented with a selective
and profound deﬁciency of NK cells in blood, unlike the
14 healthy family members tested. Moreover, three of
the NK-deﬁcient patients were tested before the onset of
any unusual infectious disease associated with EBV in-
fection. This suggests that the documented NK cell de-
ﬁciency in the index patient was a cause, rather than a
consequence, of the EBV-driven lymphoma. Neverthe-
less, although unlikely, we cannot exclude on solely clin-
ical grounds the possibility that NK deﬁciency in the
four patients was a consequence of viral illness.
The kindred lives in Ireland, and its members are all
of Irish nomadic descent (ﬁg. 1). The kindred is inbred,
with multiple loops of consanguinity. The members of
the fourth generation belong to three sibships. The par-
ents of each sibship are consanguineous, and the parents
of the three sibships are related to each other. The par-
ents of the ﬁrst sibship (III.1 and III.2) are ﬁrst cousins,
and the parents of the second (III.3 and III.5) and third
(III.6 and III.4) sibships are doubly ﬁrst cousins. These
three couples are also related to each other. The obser-
vation of NK cell deﬁciency in four related patients from
an extended inbred kindred suggested that this immu-
nological phenotype was inherited as an autosomal re-
cessive trait and that NK deﬁciency was the predisposing
factor to viral infections. We tested this hypothesis by
performing a genomewide scan by homozygosity map-
ping in this family (Lander and Botstein 1987). In a
primary screen, 13 informative family members (ﬁg. 1)
were studied by genotyping a panel of 388 highly in-
formative microsatellite markers covering the entire ge-
nome at intervals of ∼10 cM (ABI Prism Linkage Map-
ping set 2, version 2.5 [Applied Biosystems]). Genetic
distances between markers were derived from the
Marshﬁeld database. Because of the complexity of the
family structure, the analysis was performed by splitting
Ta
bl
e
1
Pa
ra
m
et
er
s
of
B
lo
od
Sa
m
pl
es
fr
om
th
e
Fo
ur
Pa
ti
en
ts
an
d
H
ea
lt
hy
C
on
tr
ol
s
PA
R
A
M
E
T
E
R
SA
M
P
L
E
S
F
R
O
M
PA
T
IE
N
T
a
H
E
A
L
T
H
Y
C
O
N
T
R
O
L
Sb
P1
(
)
n
p
8
P2
(
)
n
p
7
P3
(
)
n
p
5
P4
(
)
n
p
5
A
ge
G
ro
up
1
(
)
n
p
33
A
ge
G
ro
up
2
(
)
n
p
35
A
ge
G
ro
up
3
(
)
n
p
23
A
ge
ra
ng
ec
(y
ea
rs
)
1–
6
9–
12
2–
7
3–
5
2–
5
5–
10
10
–1
6
Ly
m
ph
oc
yt
es
d
5,
19
5
(2
,8
79
–7
,2
21
)
1,
56
7
(1
,2
38
–4
,1
97
)
2,
44
3
(1
,8
95
–4
,0
37
)
4,
28
1
(3
,8
91
–5
,3
74
)
3,
30
0
(1
,7
00
–6
,9
00
)
2,
80
0
(1
,1
00
–5
,9
00
)
2,
20
0
(1
00
–5
,3
00
)
B
ce
lls
(C
D
19

)d
1,
40
0
(8
35
–2
,2
73
)
24
7
(1
56
–9
32
)
53
8
(4
46
–7
94
)
1,
26
6
(1
,0
99
–1
,4
30
)
80
0
(2
00
–2
,1
00
)
50
0
(2
00
–1
,6
00
)
30
0
(2
00
–6
00
)
T
ce
lls
(C
D
3
)d
3,
65
1
(1
,9
00
–5
,1
45
)
1,
34
3
(1
,0
11
–3
,2
31
)
1,
85
0
(1
,3
66
–3
,2
85
)
2,
77
5
(2
,6
47
–3
,9
03
)
2,
30
0
(9
00
–4
,5
00
)
1,
90
0
(7
00
–4
,2
00
)
1,
50
0
(8
00
–3
,5
00
)
C
D
3
an
d
C
D
4
ce
lls
d
2,
82
1
(1
,2
56
–3
,4
90
)
94
1
(3
83
–2
,1
90
)
1,
50
7
(1
,0
40
–3
,0
84
)
1,
84
4
(1
,6
79
–2
,6
80
)
1,
30
0
(5
00
–2
,4
00
)
1,
00
0
(3
00
–2
,0
00
)
80
0
(4
00
–2
,1
00
)
C
D
3
an
d
C
D
8
ce
lls
d
85
2
(4
82
–1
,3
13
)
62
0
(3
37
–8
84
)
18
8
(7
7–
38
6)
1,
03
4
(8
76
–1
,3
32
)
80
0
(3
00
–1
,6
00
)
80
0
(3
00
–1
,8
00
)
40
0
(2
00
–1
,2
00
)
N
K
ce
lls
(C
D
3
,
C
D
56

,
an
d
C
D
16

):
C
ou
nt
d
12
8
(8
1–
18
1)
32
(2
4–
90
)
37
(6
–4
3)
50
(2
9–
14
9)
40
0
(1
00
–1
,0
00
)
30
0
(9
0–
90
0)
30
0
(7
0–
1,
20
0)
Pe
rc
en
ta
ge
e
(%
)
1–
4
1–
3
0–
2
1–
3
4–
23
4–
26
6–
27
N
O
T
E
.—
N
or
m
al
va
lu
es
of
th
e
he
al
th
y
co
nt
ro
ls
w
er
e
st
ud
ie
d
by
C
om
an
s-
B
it
te
r
et
al
.
(1
99
7)
.
a
n
p
N
um
be
r
of
bl
oo
d
sa
m
pl
es
fr
om
th
e
pa
ti
en
t.
b
n
p
N
um
be
r
of
he
al
th
y
ch
ild
re
n
te
st
ed
to
es
ta
bl
is
h
th
e
no
rm
al
va
lu
es
.
c
Fo
r
pa
ti
en
ts
,
ra
ng
e
of
ag
es
at
w
hi
ch
sa
m
pl
es
w
er
e
ob
ta
in
ed
;f
or
he
al
th
y
co
nt
ro
ls
,r
an
ge
of
ag
es
fo
r
al
l
ch
ild
re
n
in
th
at
gr
ou
p.
d
D
at
a
ar
e
ce
lls
/m
m
3
.F
or
pa
ti
en
ts
,
va
lu
es
ar
e
m
ed
ia
n
an
d
ra
ng
e.
Fo
r
he
al
th
y
co
nt
ro
ls
,v
al
ue
s
ar
e
m
ed
ia
n
an
d
in
te
rq
ua
rt
ile
ra
ng
e
(i
.e
.,
5t
h–
95
th
pe
rc
en
ti
le
s)
.
e
Fo
r
pa
ti
en
ts
,
th
e
ra
ng
e
of
pe
rc
en
ta
ge
s
of
ly
m
ph
oc
yt
es
th
at
w
er
e
N
K
ce
lls
;
fo
r
he
al
th
y
co
nt
ro
ls
,t
he
in
te
rq
ua
rt
ile
ra
ng
e
of
th
e
pe
rc
en
ta
ge
s
of
ly
m
ph
oc
yt
es
th
at
w
er
e
N
K
ce
lls
.
www.ajhg.org The American Journal of Human Genetics Volume 78 April 2006 725
Figure 2 Multipoint linkage analysis of chromosome region 8p12-q12.2 by homozygosity mapping. Microsatellite positions are given in
cM. A total of nine microsatellites were genotyped between D8S1821 and D8S1745.
the pedigree into two parts. Two-point and multipoint
LOD score values were calculated using GENEHUN-
TER (Kruglyak et al. 1996) and MERLIN (Abecasis
and Wigginton 2005), under the assumption that the
gene responsible for the defect was fully penetrant
and autosomal recessive. We identiﬁed six chromosomal
regions that were possibly linked with NK cell deﬁ-
ciency—that is, with a multipoint LOD score 11 after
the primary genomewide scan.
In these regions (2p21, 2p15, 6q27, 7p22.2, 8p12-
q12.2, and 8q24.13), we genotyped additional micro-
satellites (4, 3, 2, 2, 8, and 19 microsatellites, respec-
tively) in the 13 members of the family who had been
genotyped previously. This ﬁne mapping increased the
LOD score in only one region, 8p12-q12.2, which had
already yielded the highest LOD score in the primary
screen. We then genotyped 10 additional microsatellites
in this region. The 18 markers covering the region were
also genotyped in six additional healthy siblings of P1
(ﬁg. 1). The results of the multipoint linkage analysis
are shown in ﬁgure 2. A maximum LOD score of 4.51
was obtained at marker D8S532. The region of interest
(8p11.23-q11.21) overlaps the centromeric region of
chromosome 8 and ranges from D8S1821 to D8S1745
(3.2 cM). The four patients are homozygous for the
same haplotype in this region. This corresponds to a
physical distance of 12 Mb that contains 59 genes. Thir-
teen of the genes have been described as being expressed
in lymphoid cells (DKFZp586M1819, FNTA, VDAC3,
GOLGA7, INDO, BLP1, PLEKHA2, TACC1, UBE2V2,
CEBPD, IKBKB, POLB, and PRKDC). Twelve knock-
out mice for genes in this region have been generated,
including two mutants of lymphoid-expressed genes
(Polb, Prkdc, SnaI2, Chrna6, Chrnb3, Vdac3, Plat,
Ap3m2, Sfrp1, Adam2, Adam9, and Ank1). One knock-
out (Prkdc) mouse presented with a lack of both T and
B cells, but NK cells were not studied. In conclusion,
our genomewide scan clearly identiﬁed a locus located
on chromosome 8p11.23-q11.21 that is responsible for
NK cell deﬁciency in this family, providing strong evi-
dence that the patients had viral infections as a conse-
quence of a primary defect of NK cell development.
We describe here the ﬁrst multiplex kindred with a
primary, selective deﬁcit of NK cells. The four related
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patients from a large inbred kindred of Irish nomadic
descent had very small numbers of NK cells in blood.
The other two cases of possible NK cell deﬁciency re-
ported in the literature (Biron et al. 1989; Etzioni et al.
2005) were sporadic, so it is unclear whether NK cell
deﬁciency was heritable, whereas heritability was clear
in the multiplex kindred described here. The observation
that three of the four children in whom theNK cell defect
was found were ill with viral disease suggests that NK
cell deﬁciency was a cause, rather than a consequence,
of viral disease, such as the EBV-driven lymphoma di-
agnosed in the index patient. Moreover, that patient was
seronegative for EBV nuclear antigen, which is remin-
iscent of the abnormal EBV serology documented in
patients with the related disorder X-linked lymphopro-
liferative syndrome, characterized by low cytotoxic ac-
tivity of NK cells and predisposition to EBV-driven lym-
phoma (Nichols et al. 2005). Unlike the two siblings
we described in a previous study, who additionally had
neutropenia, facial dysmorphy, and severe intrauterine
growth retardation (Bernard et al. 2004), these four
patients displayed no overt biological and clinical ab-
normalities other than NK cell deﬁciency and viral
susceptibility, with the possible exception of growth re-
tardation that may or may not have been secondary to
infection. Above all, the conclusive identiﬁcation (LOD
score 4.51) of a single chromosomal region linked to
NK cell deﬁciency by homozygosity mapping unam-
biguously indicates that NK cell deﬁciency was indeed
inherited as a Mendelian trait and was probably re-
sponsible for susceptibility to viruses.We cannot exclude
the possibility that the disease-causing locus governed
susceptibility to viruses, which in turn resulted in NK
deﬁciency. This is unlikely, however, because one of the
four patients had NK deﬁciency in the absence of any
known severe viral disease. The kindred studied there-
fore deﬁne a novel Mendelian disorder that should be
registered in the McKusick catalog of Mendelian con-
ditions of man (McKusick 1998). The identiﬁcation of
a region on chromosome 8 linked to NK cell deﬁciency
should facilitate the search for the disease-causing gene.
One of the patients with sporadic disease who were pre-
viously described as having NK cell deﬁciency, who was
born to consanguineous parents (Etzioni et al. 2005), is
heterozygous in this region (data not shown), which ex-
cludes the involvement of this candidate region in that
patient’s condition.
The occurrence of EBV-driven lymphoproliferative
disorder in our index patient suggests that human NK
cells are involved in anti-EBV immunity, antitumor im-
munity, or both. Three of the four patients were sero-
positive and controlled EBV primo-infection well clini-
cally, which suggests that NK deﬁciency was involved
in impaired control of latent EBV infection or tumor
genesis rather than that of EBV primo-infection. Two of
the four patients appeared to be vulnerable to other vi-
ruses—notably, those associated with pulmonary dis-
ease—although no speciﬁc virus could be documented.
The patients were, however, resistant to other viruses,
including some herpes viruses such as HSV and VZV,
perhaps because of residual levels of NK cells. A longer
follow-up period is required before we can draw ﬁrm
conclusions about the range of susceptibility and resis-
tance to viruses and tumors in these patients. The viral
susceptibility of our index patient seems to be similar
but not identical to those of the children described in
previous studies who were given a diagnosis of possible
NK cell deﬁciency, whose EBV status was unknown or
negative, and who had VZV, HSV, and CMV infections
(Biron et al. 1989; Bernard et al. 2004; Etzioni et al.
2005). Therefore, as in mice (Casanova et al. 2001; Lee
et al. 2001; French and Yokoyama 2003), NK cells seem
to be important for the control of viruses in humans.
Interindividual differences in viral disease susceptibility
may reﬂect the complex interplay between host and en-
vironmental factors in the course of infection (Casanova
and Abel 2004, 2005). Clearly, more families with in-
herited NK cell deﬁciency must be identiﬁed before we
can reach a comprehensive understanding of the func-
tion of human NK cells in host defenses. The identiﬁ-
cation of the genomic region on chromosome 8p11.23-
q11.21 that controls NK cell development in our kin-
dred should nonetheless shed new light on NK cell
development.
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